Table 4 Intraoperative data and postoperative outcomes after PSM
Variables | Non-Wrapping Group (n = 48) | Wrapping Group (n = 48) | P value | |
|---|---|---|---|---|
Operation time (min) | 400(343–479) | 393(339–444) | 0.244 | |
Blood loss (ml) | 400(200–600) | 200(125–306) | < 0.001 | |
PPH | 11(22.9%) | 5(10.4%) | 0.100 | |
PPH A | 9(18.8%) | 5(10.4%) | 0.247 | |
PPH B | 2(4.2%) | 0 | 0.153 | |
PPH C | 0 | 0 | 1.000 | |
POPF | 18(37.5%) | 7(14.6%) | 0.011 | |
POPF A | 7(14.6%) | 6(12.5%) | 0.765 | |
POPF B | 5(10.4%) | 1(2.1%) | 0.050 | |
POPF C | 5(10.4%) | 0 | 0.022 | |
Bile leakage | 5(10.4%) | 2(4.2%) | 0.239 | |
DGE | 6(12.5%) | 7(14.6%) | 0.765 | |
Diarrhoea | 5(10.4%) | 9(18.8%) | 0.247 | |
Clavien–Dindo I-II | 10(20.8%) | 11(22.9%) | 0.805 | |
Clavien–Dindo III–V | 16(33.3%) | 5(10.4%) | 0.007 | |
Intra-abdominal infection | 19(39.6%) | 16(33.3%0 | 0.525 | |
Bowel obstruction | 4(8.3%) | 1(2.1%) | 0.168 | |
Time to remove first drainage tube (days) | 7(6–9) | 8(6–8) | 0.306 | |
Time to remove all drainage tube (days) | 14(10–20) | 12(10–17) | 0.690 | |
PHS (days) | 15(12–23) | 14(12–19) | 0.394 | |
Tumor source | Pancreas | 22(45.8%) | 26(54.2%) | 0.557 |
Ampulla | 7(14.6%) | 8(16.7%) | ||
Duodenum | 15(31.3%) | 8(16.7%) | ||
Bile duct | 3(6.3%) | 4(8.3%) | ||
Other | 1(2.1%) | 2(4.2%) | ||
R0 resection | 48(100%) | 47(97.9%) | 0.315 | |
Harvested lymph nodes | 15(12–18) | 17(12–21) | 0.085 | |
Lymphatic metastasis | 0.50(1.27) | 0.50(1.22) | 1.000 | |